TREATMENT WITH BCR INHIBITORS INCREASES ROR1 EXPRESSION IN CLL CELLS

被引：0
|
作者：
Kotaskova, J. [1 ,2 ,3 ]
Pavlova, S. [1 ,2 ,3 ]
Plevova, K. [1 ,2 ,3 ]
Malcikova, J. [1 ,2 ,3 ]
Stehlikova, O. [1 ,2 ]
Poppova, L. [1 ,2 ]
Kockova, H. [1 ,2 ]
Doubek, M. [2 ,3 ,4 ]
Bryja, V. [5 ]
Pospisilova, S. [1 ,2 ,3 ]
机构：
[1] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, CMBGT, Brno, Czech Republic
[2] Masaryk Univ, Fac Med, Brno, Czech Republic
[3] Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic
[4] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic
[5] Masaryk Univ, Fac Sci, Inst Expt Biol, Brno, Czech Republic
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1009
引用
收藏
页码：414 / 414
页数：1
相关论文
共 50 条
  • [41] Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development
    [J]. Development Genes and Evolution, 2001, 211 : 161 - 171
  • [42] THE RECEPTOR TYROSINE KINASES ROR1 AND ROR2 EXPRESSION PATTERNS IN LYMPHOID AND MYELOID MALIGNANCIES
    Manesh, A. Danesh
    Porwit, A.
    Hojjat-Farsangi, M.
    Jeddi-Tehrani, M.
    Tamm, K. Pokrovskaja
    Grander, D.
    Lehmann, S.
    Norin, S.
    Shokri, F.
    Rabbani, H.
    Mellstedt, H.
    Osterborg, A.
    [J]. HAEMATOLOGICA, 2012, 97 : 520 - 520
  • [43] Structure-based screening for potential ROR1 inhibitors and their potential as antitumor agents in pancreatic cancer cells
    Singh, Indrakant Kumar
    Gupta, Shradheya R. R.
    Mittal, Pooja
    Soni, Shivani
    Lo, Jae Ho
    Battaglin, Francesca
    Yang, Yan
    Torres-Gonzalez, Lesly
    Algaze, Sandra
    Jayachandran, Priya
    Ashouri, Karam
    Wong, Alexandra
    Zhang, Wu
    Millstein, Joshua
    Lenz, Heinz Josef
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [44] Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development
    Al-Shawi, R
    Ashton, SV
    Underwood, C
    Simons, JP
    [J]. DEVELOPMENT GENES AND EVOLUTION, 2001, 211 (04) : 161 - 171
  • [45] Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development
    Matsuda, T
    Nomi, M
    Ikeya, M
    Kani, S
    Oishi, I
    Terashima, T
    Tawada, S
    Minami, Y
    [J]. MECHANISMS OF DEVELOPMENT, 2001, 105 (1-2) : 153 - 156
  • [46] Targeting ROR1 identifies new treatment strategies in hematological cancers
    Karvonen, Hanna
    Niininen, Wilhelmiina
    Murumagi, Astrid
    Ungureanu, Daniela
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2017, 45 : 457 - 464
  • [47] ROR1 expression correlated with poor clinical outcome in human ovarian cancer
    Zhang, Huilin
    Qiu, Jinrong
    Ye, Chunping
    Yang, Dazhen
    Gao, Lingjuan
    Su, Yiping
    Tang, Xiaojun
    Xu, Ning
    Zhang, Dawei
    Xiong, Lin
    Mao, Yuan
    Li, Fengshan
    Zhu, Jin
    [J]. SCIENTIFIC REPORTS, 2014, 4
  • [48] High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia
    Emanuela M. Ghia
    Laura Z. Rassenti
    Michael Y. Choi
    Miguel Quijada-Álamo
    Elvin Chu
    George F. Widhopf
    Thomas J. Kipps
    [J]. Leukemia, 2022, 36 : 1609 - 1618
  • [49] High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia
    Ghia, Emanuela M.
    Rassenti, Laura Z.
    Choi, Michael Y.
    Quijada-Alamo, Miguel
    Chu, Elvin
    Widhopf, George F., II
    Kipps, Thomas J.
    [J]. LEUKEMIA, 2022, 36 (06) : 1609 - 1618
  • [50] Expression of ROR1 has prognostic significance in triple negative breast cancer
    Hui-Ping Chien
    Shir-Hwa Ueng
    Shin-Cheh Chen
    Yu-Sun Chang
    Yung-Chang Lin
    Yun-Feng Lo
    Hsien-Kun Chang
    Wen-Yu Chuang
    Yi-Ting Huang
    Yun-Chung Cheung
    Shih-Che Shen
    Chuen Hsueh
    [J]. Virchows Archiv, 2016, 468 : 589 - 595
12345